10,000
Participants
Start Date
August 1, 2021
Primary Completion Date
August 1, 2024
Study Completion Date
September 1, 2024
Artificial intelligence diagnosis
Participants were divided into the intervention group and the control group using a random number table. The intervention group participants' cervical colposcopic image data and non-image data as follow:age, the infection of high-risk human papillomavirus (HR-HPV),the type of HR-HPV infection,the duration of HR-HPV infection, cervical cytology (TCT) results, HIV/sexually transmitted infection history, marriage and childbearing history,first sexual life history, sexual partner history, smoking history,oral contraceptives history,the use of immune drug and possible clinical symptoms of cervical lesions such as postcoital bleeding, abnormal vaginal secretions, vaginal bleeding symptoms, etc.
RECRUITING
Fujian Maternity and Child Health Hospital, Fuzhou
RECRUITING
Mindong Hospital of Ningde City, Ningde
RECRUITING
Jianou Maternal and child Health Care Hospital, Nanping
RECRUITING
Ningde Hospital affiliated to Ningde Normal University, Ningde
RECRUITING
Quanzhou First Hospital, Quanzhou
Fujian Maternity and Child Health Hospital
OTHER